Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02785250
Title Study of DPX-Survivac Vaccine Therapy and Epacadostat in Patients With Recurrent Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors ImmunoVaccine Technologies, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Stanford University Palo Alto California 94304 United States Details
Georgia Cancer Center at Augusta University Augusta Georgia 30912 United States Details
Lenox Hill Hospital New York New York 10028 United States Details
Oregon Health & Sciences University, Knight Cancer Institute Portland Oregon 97239 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Mary Crowley Cancer Research Center Dallas Texas 75230 United States Details
Tom Baker Cancer Centre Calgary Alberta Canada Details
Princess Margaret Hospital Toronto Ontario M5G 2M9 Canada Details
Centre Hospitalier de l'Université de Montréal (CHUM) Montréal Quebec H2X 3E4 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field